Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Jan 1;110(4):975–985. doi: 10.1002/cpt.2135

Figure 2.

Figure 2

Linear regression analyses of the relationship between the wGRS and log-transformed NMR in the A) training set (N=954; combined PNAT2 and KIS3 trials), and B) replication set (N=216; Q2L trial). The wGRS explained A) 32.4% of the variance in log-NMR in the training set and B) 34.3% in the replication set